ResearcherAzienda Ospedaliera Universitaria Integrata VeronaNo recent work listed
Stefano Andrianello
Matched on ORCID iD 0000-0003-0556-8271; OpenAlex author ID A5050615738.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Collaborators
- 20
2017: 1 paper · 2018: 4 papers
Papers 5
- Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma? Co-author DOI 10.1016/j.hpb.2017.10.017↗
- Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results. Co-author DOI 10.1016/j.pan.2018.04.002↗
- Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications. Co-author DOI 10.1245/s10434-017-6281-9↗
- ASO Author Reflections: Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer. First author DOI 10.1245/s10434-018-6874-y↗
- Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM. Co-author DOI 10.1097/sla.0000000000001837↗
Closest collaborators
The 20 strongest of 20 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Giovanni Marchegiani · 5 shared papers, 2017–2018
- Paper ASO Author Reflections: Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer. DOI 10.1245/s10434-018-6874-y↗
- Paper Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma? DOI 10.1016/j.hpb.2017.10.017↗
- Paper Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoper… DOI 10.1245/s10434-017-6281-9↗
- Roberto Salvia · 5 shared papers, 2017–2018
- Paper ASO Author Reflections: Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer. DOI 10.1245/s10434-018-6874-y↗
- Paper Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma? DOI 10.1016/j.hpb.2017.10.017↗
- Paper Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoper… DOI 10.1245/s10434-017-6281-9↗
- Giuseppe Malleo · 4 shared papers, 2017–2018
- Paper Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma? DOI 10.1016/j.hpb.2017.10.017↗
- Paper Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoper… DOI 10.1245/s10434-017-6281-9↗
- Paper Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM. DOI 10.1097/sla.0000000000001837↗
- Laura Maggino · 4 shared papers, 2017–2018
- Paper Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma? DOI 10.1016/j.hpb.2017.10.017↗
- Paper Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoper… DOI 10.1245/s10434-017-6281-9↗
- Paper Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM. DOI 10.1097/sla.0000000000001837↗
- Claudio Bassi · 4 shared papers, 2017–2018
- Paper Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma? DOI 10.1016/j.hpb.2017.10.017↗
- Paper Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoper… DOI 10.1245/s10434-017-6281-9↗
- Paper Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM. DOI 10.1097/sla.0000000000001837↗
- Erica Secchettin · 2 shared papers, 2018
- Paper Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma? DOI 10.1016/j.hpb.2017.10.017↗
- Paper Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and propor… DOI 10.1016/j.pan.2018.04.002↗
- Salvatore Paiella · 2 shared papers, 2018
- Paper Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoper… DOI 10.1245/s10434-017-6281-9↗
- Paper Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and propor… DOI 10.1016/j.pan.2018.04.002↗
- Aldo Scarpa Scarpa · 2 shared papers, 2017–2018
- Paper Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM. DOI 10.1097/sla.0000000000001837↗
- Paper Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and propor… DOI 10.1016/j.pan.2018.04.002↗
- Giampaolo Perri · 1 shared paper, 2018
- Marta Sandini · 1 shared paper, 2018
- Carlos Fernández-del Castillo · 1 shared paper, 2017
- Mari A. Mino-Kenudson · 1 shared paper, 2017
- Cristina Rosa Ferrone · 1 shared paper, 2017
- Keith D. Lillemoe · 1 shared paper, 2017
- Matteo De Pastena · 1 shared paper, 2018
- Massimiliano Tuveri · 1 shared paper, 2018
- Alessandro Esposito · 1 shared paper, 2018
- Riccardo De Robertis Lombardi · 1 shared paper, 2018
- Mirko D’Onofrio · 1 shared paper, 2018
- Davide Melisi · 1 shared paper, 2018
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.